197 related articles for article (PubMed ID: 32075104)
1. Chemoradiotherapy Increases Intratumor Heterogeneity of HPSE Expression in the Relapsed Glioblastoma Tumors.
Suhovskih AV; Kazanskaya GM; Volkov AM; Tsidulko AY; Aidagulova SV; Grigorieva EV
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075104
[TBL] [Abstract][Full Text] [Related]
2. Heparan Sulfate Glycosaminoglycans in Glioblastoma Promote Tumor Invasion.
Tran VM; Wade A; McKinney A; Chen K; Lindberg OR; Engler JR; Persson AI; Phillips JJ
Mol Cancer Res; 2017 Nov; 15(11):1623-1633. PubMed ID: 28778876
[TBL] [Abstract][Full Text] [Related]
3. Heparanase Promotes Glioma Progression and Is Inversely Correlated with Patient Survival.
Kundu S; Xiong A; Spyrou A; Wicher G; Marinescu VD; Edqvist PD; Zhang L; Essand M; Dimberg A; Smits A; Ilan N; Vlodavsky I; Li JP; Forsberg-Nilsson K
Mol Cancer Res; 2016 Dec; 14(12):1243-1253. PubMed ID: 27565180
[TBL] [Abstract][Full Text] [Related]
4. Heparan Sulfate Biosynthetic System Is Inhibited in Human Glioma Due to EXT1/2 and HS6ST1/2 Down-Regulation.
Ushakov VS; Tsidulko AY; de La Bourdonnaye G; Kazanskaya GM; Volkov AM; Kiselev RS; Kobozev VV; Kostromskaya DV; Gaytan AS; Krivoshapkin AL; Aidagulova SV; Grigorieva EV
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29104277
[TBL] [Abstract][Full Text] [Related]
5. Involvement of Heparan Sulfate and Heparanase in Neural Development and Pathogenesis of Brain Tumors.
Xiong A; Spyrou A; Forsberg-Nilsson K
Adv Exp Med Biol; 2020; 1221():365-403. PubMed ID: 32274718
[TBL] [Abstract][Full Text] [Related]
6. Heparan sulfate accumulation and perlecan/HSPG2 up-regulation in tumour tissue predict low relapse-free survival for patients with glioblastoma.
Kazanskaya GM; Tsidulko AY; Volkov AM; Kiselev RS; Suhovskih AV; Kobozev VV; Gaytan AS; Aidagulova SV; Krivoshapkin AL; Grigorieva EV
Histochem Cell Biol; 2018 Mar; 149(3):235-244. PubMed ID: 29322326
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of MicroRNAs in patients with glioblastoma after concomitant chemoradiotherapy.
Park EC; Kim G; Jung J; Wang K; Lee S; Jeon SS; Lee ZW; Kim SI; Kim S; Oh YT; Shin JH; Jang HS; Choi BO; Kim GH
OMICS; 2013 May; 17(5):259-68. PubMed ID: 23586679
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk between tumor cells and lymphocytes modulates heparanase expression.
Theodoro TR; Matos LL; Cavalheiro RP; Justo GZ; Nader HB; Pinhal MAS
J Transl Med; 2019 Mar; 17(1):103. PubMed ID: 30922347
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone Inhibits Heparan Sulfate Biosynthetic System and Decreases Heparan Sulfate Content in Orthotopic Glioblastoma Tumors in Mice.
Sokolov DK; Shevelev OB; Khotskina AS; Tsidulko AY; Strokotova AV; Kazanskaya GM; Volkov AM; Kliver EE; Aidagulova SV; Zavjalov EL; Grigorieva EV
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373391
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Heparanase in Pediatric Brain Tumor Cells Attenuates their Proliferation, Invasive Capacity, and
Spyrou A; Kundu S; Haseeb L; Yu D; Olofsson T; Dredge K; Hammond E; Barash U; Vlodavsky I; Forsberg-Nilsson K
Mol Cancer Ther; 2017 Aug; 16(8):1705-1716. PubMed ID: 28716813
[TBL] [Abstract][Full Text] [Related]
11. Pro-Angiogenic Effects of Latent Heparanase and Thrombin Receptor-Mediated Pathways-Do They Share a Common Ground in Melanoma Cells?
Hoß SG; Grundmann M; Benkel T; Gockel L; Schwarz S; Kostenis E; Schlesinger M; Ilan N; Vlodavsky I; Bendas G
Thromb Haemost; 2018 Oct; 118(10):1803-1814. PubMed ID: 30235481
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of heparanase in overt diabetic nephropathy.
van den Hoven MJ; Rops AL; Bakker MA; Aten J; Rutjes N; Roestenberg P; Goldschmeding R; Zcharia E; Vlodavsky I; van der Vlag J; Berden JH
Kidney Int; 2006 Dec; 70(12):2100-8. PubMed ID: 17051139
[TBL] [Abstract][Full Text] [Related]
13. Increased Expression of GRP78 Correlates with Adverse Outcome in Recurrent Glioblastoma Multiforme Patients.
Wen X; Chen X; Chen X
Turk Neurosurg; 2020; 30(1):11-16. PubMed ID: 30649790
[TBL] [Abstract][Full Text] [Related]
14. Distribution of heparan sulfate correlated with the expression of heparanase-1 and matrix metalloproteinase-9 in an ovariectomized rats skin.
Veridiano JM; Theodoro TR; Negrete BR; Petri G; da Silva Pinhal MA; de Toledo OMS
Cell Biol Int; 2020 Jul; 44(7):1458-1466. PubMed ID: 32159248
[TBL] [Abstract][Full Text] [Related]
15. Heparanase mechanisms of melanoma metastasis to the brain: Development and use of a brain slice model.
Murry BP; Blust BE; Singh A; Foster TP; Marchetti D
J Cell Biochem; 2006 Feb; 97(2):217-25. PubMed ID: 16288472
[TBL] [Abstract][Full Text] [Related]
16. Chemical toolbox to interrogate Heparanase-1 activity.
Rabinowitz ZM; Somers J; Wang Z; Cui L
Curr Opin Chem Biol; 2024 Jun; 80():102452. PubMed ID: 38555836
[TBL] [Abstract][Full Text] [Related]
17. Multiple Irradiation Affects Cellular and Extracellular Components of the Mouse Brain Tissue and Adhesion and Proliferation of Glioblastoma Cells in Experimental System In Vivo.
Politko MO; Tsidulko AY; Pashkovskaya OA; Kuper KE; Suhovskih AV; Kazanskaya GM; Klyushova LS; Sokolov DK; Volkov AM; Kliver EE; Zheravin AA; Aidagulova SV; Grigorieva EV
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948147
[TBL] [Abstract][Full Text] [Related]
18. Non-reducing end labeling of heparan sulfate via click chemistry and a high throughput ELISA assay for heparanase.
Wu ZL; Huang X; Ethen CM; Tatge T; Pasek M; Zaia J
Glycobiology; 2017 Jun; 27(6):518-524. PubMed ID: 28025251
[TBL] [Abstract][Full Text] [Related]
19. Intratumor DNA methylation heterogeneity in glioblastoma: implications for DNA methylation-based classification.
Wenger A; Ferreyra Vega S; Kling T; Bontell TO; Jakola AS; Carén H
Neuro Oncol; 2019 May; 21(5):616-627. PubMed ID: 30668814
[TBL] [Abstract][Full Text] [Related]
20. Recent data concerning heparanase: focus on fibrosis, inflammation and cancer.
Secchi MF; Masola V; Zaza G; Lupo A; Gambaro G; Onisto M
Biomol Concepts; 2015 Dec; 6(5-6):415-21. PubMed ID: 26552066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]